Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988–2013). (2nd April 2018)
- Record Type:
- Journal Article
- Title:
- Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988–2013). (2nd April 2018)
- Main Title:
- Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988–2013)
- Authors:
- Mou, Haibo
Liao, Qin
Hou, Xuehua
Chen, Te
Zhu, Yuping - Abstract:
- Abstract: Purpose: The surgery with adjuvant radiation for the treatment of thymoma is still debated. The aim of this study was to examine the efficacy of postoperative radiotherapy (PORT) in a population-based registry of patients with thymoma. Materials and methods: We conducted a retrospective analysis of the Surveillance, Epidemiology, and End Results database to compare the outcomes of patients with thymoma who received surgery with or without PORT. Results: Among the 2234 patients of this study, the surgery with PORT group had a longer mean overall survival (OS) and cancer-specific survival (CSS) than did the surgery without PORT group (OS: 172.3 vs. 155.3 months, p = .005; CSS: 247.3 vs. 241.8 months, p = .04). PORT significantly improved OS and CSS of patients with stage III/IV disease, but decreased CSS for those with stage I/IIA disease. Although the surgery with PORT group had a higher rate of secondary cancers, the between-group difference in the disease-free interval was not significant. Conclusions: PORT provides a significant benefit for patients with thymoma, particularly those with advanced disease. However, it also increases the risk of a second malignancy. We suggest that treatment guidelines should adopt a more positive stance on the use of PORT.
- Is Part Of:
- International journal of radiation biology. Volume 94:Number 5(2018)
- Journal:
- International journal of radiation biology
- Issue:
- Volume 94:Number 5(2018)
- Issue Display:
- Volume 94, Issue 5 (2018)
- Year:
- 2018
- Volume:
- 94
- Issue:
- 5
- Issue Sort Value:
- 2018-0094-0005-0000
- Page Start:
- 495
- Page End:
- 502
- Publication Date:
- 2018-04-02
- Subjects:
- Adjuvant radiotherapy -- thymoma -- thymic epithelial tumors -- second primary malignancy -- SEER -- population-based
Radiation -- Physiological effect -- Periodicals
Radiobiology -- Periodicals
571.45 - Journal URLs:
- http://www.tandfonline.com/loi/irab20 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/09553002.2018.1454618 ↗
- Languages:
- English
- ISSNs:
- 0955-3002
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.517900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6467.xml